Jacob Antunes1, Satish Viswanath2, Justin T Brady3, Benjamin Crawshaw3, Pablo Ros4, Scott Steele5, Conor P Delaney5, Raj Paspulati4, Joseph Willis6, Anant Madabhushi2. 1. Department of Biomedical Engineering, Case Western Reserve University, 309 Wickenden Building, 10900 Euclid Avenue, Cleveland, OH 44106. Electronic address: jacob.antunes@case.edu. 2. Department of Biomedical Engineering, Case Western Reserve University, 309 Wickenden Building, 10900 Euclid Avenue, Cleveland, OH 44106. 3. Department of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio. 4. Department of Radiology, University Hospitals Case Medical Center, Cleveland, Ohio. 5. Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio. 6. Department of Pathology, University Hospitals Case Medical Center, Cleveland, Ohio.
Abstract
RATIONALE AND OBJECTIVES: The objective of this study was to develop and quantitatively evaluate a radiology-pathology fusion method for spatially mapping tissue regions corresponding to different chemoradiation therapy-related effects from surgically excised whole-mount rectal cancer histopathology onto preoperative magnetic resonance imaging (MRI). MATERIALS AND METHODS: This study included six subjects with rectal cancer treated with chemoradiation therapy who were then imaged with a 3-T T2-weighted MRI sequence, before undergoing mesorectal excision surgery. Excised rectal specimens were sectioned, stained, and digitized as two-dimensional (2D) whole-mount slides. Annotations of residual disease, ulceration, fibrosis, muscularis propria, mucosa, fat, inflammation, and pools of mucin were made by an expert pathologist on digitized slide images. An expert radiologist and pathologist jointly established corresponding 2D sections between MRI and pathology images, as well as identified a total of 10 corresponding landmarks per case (based on visually similar structures) on both modalities (five for driving registration and five for evaluating alignment). We spatially fused the in vivo MRI and ex vivo pathology images using landmark-based registration. This allowed us to spatially map detailed annotations from 2D pathology slides onto corresponding 2D MRI sections. RESULTS: Quantitative assessment of coregistered pathology and MRI sections revealed excellent structural alignment, with an overall deviation of 1.50 ± 0.63 mm across five expert-selected anatomic landmarks (in-plane misalignment of two to three pixels at 0.67- to 1.00-mm spatial resolution). Moreover, the T2-weighted intensity distributions were distinctly different when comparing fibrotic tissue to perirectal fat (as expected), but showed a marked overlap when comparing fibrotic tissue and residual rectal cancer. CONCLUSIONS: Our fusion methodology enabled successful and accurate localization of post-treatment effects on in vivo MRI.
RATIONALE AND OBJECTIVES: The objective of this study was to develop and quantitatively evaluate a radiology-pathology fusion method for spatially mapping tissue regions corresponding to different chemoradiation therapy-related effects from surgically excised whole-mount rectal cancer histopathology onto preoperative magnetic resonance imaging (MRI). MATERIALS AND METHODS: This study included six subjects with rectal cancer treated with chemoradiation therapy who were then imaged with a 3-T T2-weighted MRI sequence, before undergoing mesorectal excision surgery. Excised rectal specimens were sectioned, stained, and digitized as two-dimensional (2D) whole-mount slides. Annotations of residual disease, ulceration, fibrosis, muscularis propria, mucosa, fat, inflammation, and pools of mucin were made by an expert pathologist on digitized slide images. An expert radiologist and pathologist jointly established corresponding 2D sections between MRI and pathology images, as well as identified a total of 10 corresponding landmarks per case (based on visually similar structures) on both modalities (five for driving registration and five for evaluating alignment). We spatially fused the in vivo MRI and ex vivo pathology images using landmark-based registration. This allowed us to spatially map detailed annotations from 2D pathology slides onto corresponding 2D MRI sections. RESULTS: Quantitative assessment of coregistered pathology and MRI sections revealed excellent structural alignment, with an overall deviation of 1.50 ± 0.63 mm across five expert-selected anatomic landmarks (in-plane misalignment of two to three pixels at 0.67- to 1.00-mm spatial resolution). Moreover, the T2-weighted intensity distributions were distinctly different when comparing fibrotic tissue to perirectal fat (as expected), but showed a marked overlap when comparing fibrotic tissue and residual rectal cancer. CONCLUSIONS: Our fusion methodology enabled successful and accurate localization of post-treatment effects on in vivo MRI.
Authors: Eli Gibson; Cathie Crukley; Mena Gaed; José A Gómez; Madeleine Moussa; Joseph L Chin; Glenn S Bauman; Aaron Fenster; Aaron D Ward Journal: J Magn Reson Imaging Date: 2012-07-31 Impact factor: 4.813
Authors: D M Koh; G Brown; L Temple; H Blake; A Raja; P Toomey; N Bett; S Farhat; A R Norman; I Daniels; J E Husband Journal: Eur Radiol Date: 2005-05-03 Impact factor: 5.315
Authors: N A Janjan; V S Khoo; J Abbruzzese; R Pazdur; R Dubrow; K R Cleary; P K Allen; P M Lynch; G Glober; R Wolff; T A Rich; J Skibber Journal: Int J Radiat Oncol Biol Phys Date: 1999-07-15 Impact factor: 7.038
Authors: Uday B Patel; Fiona Taylor; Lennart Blomqvist; Christopher George; Hywel Evans; Paris Tekkis; Philip Quirke; David Sebag-Montefiore; Brendan Moran; Richard Heald; Ashley Guthrie; Nicola Bees; Ian Swift; Kjell Pennert; Gina Brown Journal: J Clin Oncol Date: 2011-08-29 Impact factor: 44.544
Authors: Thomas Hambrock; Diederik M Somford; Henkjan J Huisman; Inge M van Oort; J Alfred Witjes; Christina A Hulsbergen-van de Kaa; Thomas Scheenen; Jelle O Barentsz Journal: Radiology Date: 2011-05 Impact factor: 11.105
Authors: Carlo N De Cecco; Balaji Ganeshan; Maria Ciolina; Marco Rengo; Felix G Meinel; Daniela Musio; Francesca De Felice; Nicola Raffetto; Vincenzo Tombolini; Andrea Laghi Journal: Invest Radiol Date: 2015-04 Impact factor: 6.016
Authors: Ke Nie; Liming Shi; Qin Chen; Xi Hu; Salma K Jabbour; Ning Yue; Tianye Niu; Xiaonan Sun Journal: Clin Cancer Res Date: 2016-05-16 Impact factor: 12.531
Authors: Jonathan T C Liu; Adam K Glaser; Kaustav Bera; Lawrence D True; Nicholas P Reder; Kevin W Eliceiri; Anant Madabhushi Journal: Nat Biomed Eng Date: 2021-02-15 Impact factor: 25.671
Authors: Trang T Pham; Timothy Stait-Gardner; Cheok Soon Lee; Michael Barton; Petra L Graham; Gary Liney; Karen Wong; William S Price Journal: Sci Rep Date: 2019-06-27 Impact factor: 4.379